Overview

In this role you bridge Disease Biology, Clinical Development and Portfolio & Disease Strategy to translate scientific insights into portfolio-relevant priorities. You assess biological rationale and translational robustness for opportunities, integrate cross-functional scientific inputs, and support portfolio decisions that reflect disease biology and development feasibility. You contribute to scientific guardrails and governance discussions, shaping strategic recommendations within the IMID Derma Area. This is a high-impact, cross-functional position grounded in translational science and portfolio strategy.

Responsabilidades

- Translate disease biology into portfolio-relevant scientific priorities and pre-candidate directions
- Provide preliminary assessment of biological rationale, tractability and translational robustness
- Consolidate scientific and early development inputs for cross-functional opportunity assessment
- Contribute to assessment of external assets and partnerships from a scientific portfolio perspective
- Support comparative evaluation of opportunities using agreed scientific and strategic criteria
- Ensure portfolio recommendations incorporate disease biology and clinical development viewpoints
- Support discussions around evidence requirements, biomarkers and translational strategies for POC
- Facilitate visibility of scientific and development risks for proposed opportunities
- Provide scientific input to portfolio prioritization and asset-level decisions
- Challenge assumptions on mechanism validity and early development feasibility




- Integrate Disease Biology and Clinical Development inputs into portfolio recommendations
- Define scientific guardrails for external search and opportunity filtering
- Ensure portfolio discussions reflect scientific opportunities, risks and uncertainties

Requisitos principales

- Advanced degree in Life Sciences, Medicine, Pharmacy or related scientific discipline (PhD, MD, PharmD or equivalent strongly preferred)
- 8-10+ years in biopharmaceutical industry across Disease Biology, Translational Medicine, Clinical Development, Early Development and/or Portfolio Strategy
- Strong experience in drug discovery, translational science and early clinical development
- Proven experience evaluating scientific opportunities, mechanisms of action, target biology, biomarkers and development feasibility
- Experience supporting asset strategy, portfolio reviews, governance discussions or investment decision-making
- Ability to integrate scientific, clinical and portfolio perspectives into strategic recommendations
- Experience in matrixed cross-functional environments (Research, Clinical Development, Medical Affairs, Portfolio)
- Strong understanding of external innovation assessment, licensing opportunities, due diligence inputs and screening
- Experience presenting complex scientific concepts to senior stakeholders and governance committees
- Prior experience in the IMID Derma Area space
- Excellent communication and stakeholder management skills; proficient in English; other languages appreciated

- strong communication
- stakeholder management
- cross-functional collaboration
- Translational medicine
- drug discovery
- biomarkers

📌 ASS. DIRECTOR, SCIENTIFIC PORTFOLIO & EARLY DEVELOP. IMID (Barcelona)
🏢 Almirall
📍 Barcelona